2,129 result(s) found
Earnings Estimates Moving Higher for Vanda (VNDA): Time to Buy?
https://www.zacks.com/stock/news/2224961/earnings-estimates-moving-higher-for-vanda-vnda-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2224961
Feb 12, 2024 - Vanda (VNDA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
Earnings Estimates Moving Higher for PennyMac (PFSI): Time to Buy?
https://www.zacks.com/stock/news/2224960/earnings-estimates-moving-higher-for-pennymac-pfsi-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2224960
Feb 12, 2024 - PennyMac (PFSI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
0
Taco Bell execs are confident about new menu items despite added complexity
https://www.nrn.com/operations/taco-bell-execs-are-confident-about-new-menu-items-despite-added-complexity
Feb 12, 2024 - Such added complexity, including from a new Cantina Chicken menu, comes with operational risks, such as slower service times.
0
Russia’s economy ‘in for very tough times’ despite improved growth outlook, IMF managing director says
https://www.cnbc.com/2024/02/12/russias-economy-in-for-very-tough-times-despite-improved-outlook-imf.html
Feb 12, 2024 - Russia's current production and consumption patterns are "pretty much what the Soviet Union used to look like," Georgieva said.
0
PepsiCo earnings top estimates, but quarterly revenue slides for the first time in nearly four years
https://www.cnbc.com/2024/02/09/pepsico-pep-q4-2023-earnings.html
Feb 12, 2024 - PepsiCo's revenue fell 0.5% in the fourth quarter, as it saw slower demand in North America.
0
Where's the beef? How some chains are answering that call
https://www.nrn.com/first-bite/wheres-beef-how-some-chains-are-answering-call
Feb 12, 2024 - We’ve spent a lot of time in recent years talking about chicken. Justifiably so — demand for the protein surpassed beef as younger consumers in particular prefer chicken’s health-halo, versatility, and portability.
But during all of this, a nu
0
Enliven Therapeutics Maybe Improving Kinase Inhibitors, But Too Early To Tell The Impact
https://seekingalpha.com/article/4669419-enliven-therapeutics-maybe-improving-kinase-inhibitors-but-too-early-tell-impact?source=feed_all_articles
Feb 11, 2024 - Enliven Therapeutics is a biotech specializing in targeted therapies for cancer. Click here to read what makes ELVN stock a long bet at this time.
0
Here Is the Best Way to Start Investing With $1,000 Right Now
https://www.fool.com/investing/2024/02/11/best-way-start-investing-1000-dollars-right-now/?source=iedfolrf0000001
Feb 11, 2024 - Even though the market is hitting all-time highs, investors should still be putting money to work.
0
This Passive-Income Powerhouse Just Raised Its Dividend for the 37th Consecutive Year to an All-Time High
https://www.fool.com/investing/2024/02/11/chevron-passive-income-raised-dividend-record/?source=iedfolrf0000001
Feb 11, 2024 - Chevron's 8% dividend increase, or $0.48 per share per year, is the largest such raise in company history.
0
My Defensive Equity Portfolio Is Ready For A Good Or Bad 2024
https://seekingalpha.com/article/4669244-my-defensive-equity-portfolio-is-ready-for-a-good-or-bad-2024?source=feed_tag_etf_portfolio_strategy
Feb 10, 2024 - Investors are tense about the market's all-time highs and want to exercise caution, but still stay in the market. Explore more details here.
0